Announcements Trials
Browse Landscape

Phase

Phase NA 11Phase 4 10Phase 2 4Phase 3 2Phase 2/3 2Phase 1/2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 4Pain, Postoperative 2Vesico-Ureteral Reflux 1Uterine Neoplasms 1Ureteral Neoplasms 1Peritoneal Cancer 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Neuralgia 1Nephrolithiasis 1Neoplasms 1Malignant Neoplasms of Female Genital Organs 1Lung Neoplasms 1Leiomyoma 1Kidney Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Digestive System Diseases 1Breast Cancer Female 1Abdominal Cancer 1

Interventions

Lidocaine 4Sodium Chloride 3Saline Solution 3Ropivacaine 2Pregabalin 2Ketamine 2Bupivacaine 2parecoxib 1oxycodone-acetaminophen 1Respiration 1Oxycodone 1Morphine 1Levobupivacaine 1Ketorolac Tromethamine 1Ketorolac 1Dexamethasone 1Control Groups 1Circumcision, Male 1Celecoxib 1Botulinum Toxins, Type A 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Pain, Postoperative × Bupivacaine × Clear all
NCT05763667 2025-04-24

Pilot: Intraoperative TAP Block and Post-operative Pain Control for Minimally Invasive Hysterectomy for Endometrial Cancer

Tufts Medical Center

Phase 3 Completed
15 enrolled
Gynecologic

Endometrial Hyperplasia, Pain, Postoperative, Endometrial Neoplasms

NCT03304444 2017-10-09

A Comparison of Exparel to Bupivacaine in TAP Block for Abdominal Gynecologic Surgery

Abington Memorial Hospital

Phase 3 Unknown
128 enrolled

Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡